What is the federal act that restricts the re-importation of previously exported drugs?

The Prescription Drug Marketing Act of 1987 is the federal legislation that specifically restricts the re-importation of previously exported drugs. This act was put in place primarily to ensure the safety and effectiveness of prescription drugs within the United States. It addresses issues such as drug distribution, ensuring that products are not counterfeited or tampered with and that they meet the FDA's established safety standards.

This act prohibits the re-importation of prescription drugs that have been exported unless they meet certain criteria, even if they are being returned to the original exporter. The intent behind this regulation is to prevent the influx of drugs that may not comply with U.S. regulations, which could potentially lead to public health risks.

The other options listed do not focus on the re-importation aspect. The Controlled Substances Act regulates the manufacture and distribution of controlled substances but does not specifically address the re-importation of drugs. The Drug Enforcement Administration Act pertains primarily to drug enforcement and regulation activities, while the Food, Drug, and Cosmetic Act establishes the general framework for the safety and efficacy of food and drugs but does not specifically address re-importation. Thus, the Prescription Drug Marketing Act of 1987 is the correct answer as it directly targets the re-importation issues related to